Global Locator
Genzyme Websites
Health Care Professionals
Company
Products
Research
Patients
Responsibility
Careers
News
About Genzyme
Company Leadership
Business Units
News
Press Contacts
Subscribe to News
Recognition and Awards
Working With Genzyme
Global Reach
Download Genzyme Materials
Today is April 25, 2024. All times in Eastern Daylight Time.
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada™ (*)) in Multiple Sclerosis
07/11/2011 - 01:46 AM
Mipomersen Data Presented at European Atherosclerosis Society Congress
06/28/2011 - 09:02 AM
Genzyme Corporation Announces Expiration of Consent Solicitation and Receipt of Requisite Consents
06/20/2011 - 09:02 AM
Genzyme Celebrates 20th Anniversary of Gaucher Disease Registry with Launch of New Web Platform
06/16/2011 - 08:00 AM
Genzyme Corporation Commences Consent Solicitation Relating to its Outstanding 3.625% Senior Notes due 2015 and 5.000% Senior Notes due 2020
05/24/2011 - 02:29 PM
Genzyme Revenues Grow in First-Quarter 2011
04/28/2011 - 01:30 AM
Five-year Alemtuzumab Phase 2 Data Shows Large Percentage of MS Patients Remain Free of Clinically-Active Disease
04/14/2011 - 12:00 PM
Genzyme Presents New Data from Alemtuzumab Phase 2 MS Trial at 63rd Annual Meeting of the American Academy Of Neurology
04/07/2011 - 09:06 AM
Data from Two Mipomersen Phase 3 Trials Presented at ACC
04/05/2011 - 09:00 AM
Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares
03/07/2011 - 08:00 AM
Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group
03/01/2011 - 09:00 AM
Genzyme Recognizes International Rare Disease Day by Launching New Patient Advocacy Grant Program
02/28/2011 - 07:30 AM
Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Further Improvement Across All Endpoints
02/18/2011 - 01:12 PM
Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Year
02/16/2011 - 07:00 AM
Genzyme Completes Sale of Diagnostics Business to Sekisui Chemical Co.
02/01/2011 - 08:55 AM
Genzyme Will Allow Sanofi-Aventis to Conduct Due Diligence
01/31/2011 - 08:30 AM
Genzyme to Build Additional Plant to Support Growth of Myozyme® and Lumizyme®
01/20/2011 - 07:00 AM
Genzyme Financial Recovery Continues in Fourth Quarter
01/11/2011 - 12:30 PM
Genzyme Statement on Discussions With Sanofi-Aventis
01/10/2011 - 08:14 AM
Genzyme Details Market Potential of Alemtuzumab for MS
12/20/2010 - 02:51 PM
Genzyme to Hold Investor Event on Alemtuzumab
12/13/2010 - 04:01 PM
Genzyme Reiterates Board’s Position on Sanofi-Aventis Tender Offer
12/13/2010 - 10:15 AM
Genzyme Completes Sale of Genetic Testing Business to LabCorp
12/01/2010 - 08:00 AM
Genzyme Successfully Meets First Milestones of FDA Consent Decree
11/24/2010 - 08:31 AM
Genzyme Announces Agreement to Sell Diagnostics Business to Sekisui Chemical Co.
11/18/2010 - 08:00 AM
1
2
3
4
5
6
7
8
9
10
11
12
« Previous
Next »
infoBox
LinkedIn
Yahoo! Buzz
Facebook
Twitter
Delicious
DIGG